BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7779196)

  • 1. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
    Hendricks SK; Sorensen TK; Baker ER
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated pericardial effusion in the human fetus: a report of three cases.
    Azancot A; Diehl R; Dorgeret S; Sebag G; Baumann C; Vuillard E; Machado L; Luton D; Oury JF
    Prenat Diagn; 2003 Mar; 23(3):193-7. PubMed ID: 12627418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].
    Wacker A; Scheel-Walter HG; Neunhoeffer F
    Z Geburtshilfe Neonatol; 2009 Apr; 213(2):64-6. PubMed ID: 19319796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA; Wagner T; Malisius R; Gembruch U
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hepatosplenomegaly associated with transient myeloproliferative disorder in trisomy 21.
    Macones GA; Johnson A; Tilley D; Wade R; Wapner R
    Fetal Diagn Ther; 1995; 10(2):131-3. PubMed ID: 7794514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hydrops fetalis associated with intrauterine cytomegalovirus infection: prenatal diagnosis.
    Mazeron MC; Cordovi-Voulgaropoulos L; Pérol Y
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):692-4. PubMed ID: 9205451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient abnormal myelopoiesis associated with Down syndrome presenting as severe hydrops fetalis: a case report.
    Malin GL; Kilby MD; Velangi M
    Fetal Diagn Ther; 2010; 27(3):171-3. PubMed ID: 20160425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of non-immune hydrops: 8 years' experience.
    Anandakumar C; Biswas A; Wong YC; Chia D; Annapoorna V; Arulkumaran S; Ratnam S
    Ultrasound Obstet Gynecol; 1996 Sep; 8(3):196-200. PubMed ID: 8915090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient myeloproliferative disorder and non-immune hydrops fetalis in a neonate with trisomy 21.
    Hon KL; Leung TY
    Hong Kong Med J; 2014 Feb; 20(1):78.e3-e4. PubMed ID: 24473698
    [No Abstract]   [Full Text] [Related]  

  • 15. Fetal hydrops and anemia as signs of Down syndrome.
    Sükür YE; Gözüküçük M; Bayramov V; Koç A
    J Formos Med Assoc; 2011 Nov; 110(11):716-8. PubMed ID: 22118317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report.
    Plachouras N; Stefanidis K; Andronikou S; Lolis D
    J Reprod Med; 1999 Apr; 44(4):377-80. PubMed ID: 10319311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection.
    Peters MT; Nicolaides KH
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):501-4. PubMed ID: 2154730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonimmune hydrops fetalis associated with intrauterine intussusception.
    Brinson RA; Goldsmith JP
    J Perinatol; 1988; 8(3):225-7. PubMed ID: 3066874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated fetal pleural effusion: a prenatal management dilemma.
    Hagay Z; Reece A; Roberts A; Hobbins JC
    Obstet Gynecol; 1993 Jan; 81(1):147-52. PubMed ID: 8416451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute non-lymphocytic leukaemia versus transient leukaemoid reaction in fetuses with Down syndrome.
    Gaedicke G; Kleihauer E; Terinde R
    Lancet; 1990 Apr; 335(8693):857. PubMed ID: 1969581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.